Literature DB >> 30167905

Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma.

C Mariette1, F Carneiro2, H I Grabsch3,4, R S van der Post5, W Allum6, Giovanni de Manzoni7.   

Abstract

BACKGROUND AND AIMS: Clinicopathological characteristics of gastric cancer (GC) are changing, especially in the West with a decreasing incidence of distal, intestinal-type tumours and the corresponding increasing proportion of tumours with Laurén diffuse or WHO poorly cohesive (PC) including signet ring cell (SRC) histology. To accurately assess the behaviour and the prognosis of these GC subtypes, the standardization of pathological definitions is needed.
METHODS: A multidisciplinary expert team belonging to the European Chapter of International Gastric Cancer Association (IGCA) identified 11 topics on pathological classifications used for PC and SRC GC. The topics were debated during a dedicated Workshop held in Verona in March 2017. Then, through a Delphi method, consensus statements for each topic were elaborated.
RESULTS: A consensus was reached on the need to classify gastric carcinoma according to the most recent edition of the WHO classification which is currently WHO 2010. Moreover, to standardize the definition of SRC carcinomas, the proposal that only WHO PC carcinomas with more than 90% poorly cohesive cells having signet ring cell morphology have to be classified as SRC carcinomas was made. All other PC non-SRC types have to be further subdivided into PC carcinomas with SRC component (< 90% but > 10% SRCs) and PC carcinomas not otherwise specified (< 10% SRCs).
CONCLUSION: The reported statements clarify some debated topics on pathological classifications used for PC and SRC GC. As such, this consensus classification would allow the generation of evidence on biological and prognostic differences between these GC subtypes.

Entities:  

Keywords:  Gastric cancer; Poorly cohesive sub-type; Signet ring cell histology

Mesh:

Year:  2018        PMID: 30167905     DOI: 10.1007/s10120-018-0868-0

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  29 in total

1.  Where does signet-ring cell carcinoma come from and where does it go?

Authors:  Tomio Arai
Journal:  Gastric Cancer       Date:  2019-04-08       Impact factor: 7.370

Review 2.  Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers.

Authors:  Arnulf H Hölscher; Simon Law
Journal:  Gastric Cancer       Date:  2019-11-06       Impact factor: 7.370

3.  Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.

Authors:  Kyoko Yamaguchi; Tomoyasu Yoshihiro; Hiroshi Ariyama; Mamoru Ito; Michitaka Nakano; Yuichiro Semba; Jumpei Nogami; Kenji Tsuchihashi; Takuji Yamauchi; Shohei Ueno; Taichi Isobe; Koji Shindo; Taiki Moriyama; Kenoki Ohuchida; Masafumi Nakamura; Yoshihiro Nagao; Tetsuo Ikeda; Makoto Hashizume; Hiroyuki Konomi; Takehiro Torisu; Takanari Kitazono; Tomohiro Kanayama; Hiroyuki Tomita; Yoshinao Oda; Hitoshi Kusaba; Takahiro Maeda; Koichi Akashi; Eishi Baba
Journal:  Gastric Cancer       Date:  2022-06-04       Impact factor: 7.701

4.  Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.

Authors:  Alberto Puccini; Kelsey Poorman; Fabio Catalano; Andreas Seeber; Richard M Goldberg; Mohamed E Salem; Anthony F Shields; Martin D Berger; Francesca Battaglin; Ryuma Tokunaga; Madiha Naseem; Wu Zhang; Philip A Philip; John L Marshall; W Michael Korn; Heinz-Josef Lenz
Journal:  Oncogene       Date:  2022-05-26       Impact factor: 8.756

Review 5.  Cancer biology as revealed by the research autopsy.

Authors:  Christine A Iacobuzio-Donahue; Chelsea Michael; Priscilla Baez; Rajya Kappagantula; Jody E Hooper; Travis J Hollman
Journal:  Nat Rev Cancer       Date:  2019-09-13       Impact factor: 60.716

Review 6.  Gastric Signet Ring Cell Carcinoma: Current Management and Future Challenges.

Authors:  Yang Li; Zhikai Zhu; Fuhai Ma; Liyan Xue; Yantao Tian
Journal:  Cancer Manag Res       Date:  2020-09-03       Impact factor: 3.989

7.  Transcriptome Analysis and the Prognostic Role of NUDC in Diffuse and Intestinal Gastric Cancer.

Authors:  Sang-Ho Jeong; Miyeong Park; Sun Yi Park; Jiho Park; Tae-Han Kim; Young-Joon Lee; Eun-Jung Jung; Young-Tae Ju; Chi-Young Jeong; Ju-Yeon Kim; Gyung Hyuck Ko; Minhye Kim; Ki Taek Nam; James R Goldenring
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

8.  Her2-Positive and Microsatellite Instability Status in Gastric Cancer-Clinicopathological Implications.

Authors:  Ana Bermúdez; Isabel Arranz-Salas; Silvia Mercado; Juan A López-Villodres; Virginia González; Francisca Ríus; María V Ortega; Carmen Alba; Isabel Hierro; Diego Bermúdez
Journal:  Diagnostics (Basel)       Date:  2021-05-25

9.  Extranodal soft tissue metastasis as an independent prognostic factor in gastric cancer patients aged under 70 years after curative gastrectomy.

Authors:  Nannan Zhang; Jingyu Deng; Weilin Sun; Yingxin Du; Shiwei Guo; Huihui Bai; Huifang Liu; Han Liang
Journal:  Ann Transl Med       Date:  2020-03

Review 10.  Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer.

Authors:  K G P Kerckhoffs; D H W Liu; L Saragoni; R S van der Post; R Langer; M Bencivenga; M Iglesias; G Gallo; L C Hewitt; G E Fazzi; A M Vos; F Renaud; T Yoshikawa; T Oshima; A Tomezzoli; G de Manzoni; T Arai; R Kushima; F Carneiro; H I Grabsch
Journal:  Gastric Cancer       Date:  2020-06-02       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.